Ireland’s premier life sciences celebration recognises industry excellence with 217 attendees witnessing record-breaking competition across 22 categories ...

Scientists from Cincinnati Children's and colleagues based in Japan report achieving a major step forward in organoid ...

The sixth edition of the popular event features 72 teams competing at Midland Country Club for a $3.3 million purse.

The U.S. Intravenous Immunoglobulin Market plays a crucial role in treating immunodeficiency diseases and various autoimmune disorders, reflecting a steady evolution influenced by advanced therapies ...

ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...

Guselkumab, whether administered every 4 or 8 weeks, demonstrates “significant inhibition” of structural damage in patients ...

This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.

Rusfertide is an investigational, first-in-class hepcidin mimetic peptide therapeutic that aims to regulate iron homeostasis ...

1, Mi Hyang Lee, 9. 2 (tie), Yealimi Noh and Madelene Sagstrom, 8. 4 (tie), Rio Takeda and Chanettee Wannasaen, 7. 6, 8 tied with 6. 1, Xiaowen Yin, .67%. 2, Jin Hee Im, .60%. 3 (tie), Madelene ...